NCT07749547 Using Personalized Rehabilitation to Reduce Disease and Increase Activity of Patients With Polymyalgia Rheumatica
| NCT ID | NCT07749547 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Washington University School of Medicine |
| Condition | Polymyalgia Rheumatica (PMR) |
| Study Type | INTERVENTIONAL |
| Enrollment | 20 participants |
| Start Date | 2026-08-15 |
| Primary Completion | 2027-03-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 20 participants in total. It began in 2026-08-15 with a primary completion date of 2027-03-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Polymyalgia rheumatica (PMR) is a condition that causes joint pain and stiffness, making it hard for people to do everyday tasks. Movement pattern training is a special, personalized rehabilitation program that aims to reduce pain by improving how people move during their daily activities. The investigators plan to test if it's possible to conduct a detailed study to find out how effective Movement pattern training is for people with PMR. The investigators will look at whether it helps them perform activities they want to do, reduce their use of certain medications, and strengthen their muscles. The investigators will also gather feedback from patients about their experience with Movement pattern training. This study will help us understand if carrying out a larger study on Movement pattern training's effectiveness is practical.
Eligibility Criteria
Inclusion Criteria: * Patient reports pain \> 3 (0-10, 0 = no pain; 10 = worst pain imaginable) * Diagnosis or flare of PMR according to the European League against Rheumatism/American College of Rheumatology (EULAR/ACR) classification criteria as follows (must satisfy all criteria)10: * Age ≥50 years at time of diagnosis * Presence of bilateral shoulder pain * Elevated acute phase reactants C-reactive protein (CRP) \>10 milligram/Liter and/or Erythrocyte Sedimentation Rate (ESR) \>30 millimeters/hour\* * A score ≥4 at the time of diagnosis based on the following (without ultrasound): * Duration of morning stiffness \>45 minutes: 2 points * Hip pain or limited range of motion: 1 point * Seronegative for rheumatoid factor and anti-cyclic citrullinated peptide: 2 points * Absence of other joint involvement: 1 point * Able to give informed consent * Physician's clearance to participate in physical activity Exclusion Criteria: * Diagnosis of fibromyalgia, neuropathic muscular disease, complex regional pain syndrome, or small fiber neuropathy * planned major surgical procedure during the study * Current active uncontrolled infection
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07749547 clinical trial?
This trial is open to participants of all sexes, aged 50 Years or older, studying Polymyalgia Rheumatica (PMR). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07749547 currently recruiting?
Yes, NCT07749547 is actively recruiting participants. Contact the research team at harrisma@wustl.edu for enrollment information.
Where is the NCT07749547 trial being conducted?
This trial is being conducted at St Louis, United States.
Who is sponsoring the NCT07749547 clinical trial?
NCT07749547 is sponsored by Washington University School of Medicine. The trial plans to enroll 20 participants.